Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v2.4.0.6
INCOME TAXES (Tables)
12 Months Ended
Jun. 30, 2012
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] The components of the Company’s deferred tax assets are as follows:

 

 

 

 

 

 

 

 

 

 

As of June 30,

 

 

 


 

 

 

2012

 

2011

 

 

 


 


 

 

 

 

 

 

 

 

 

Deferred tax assets:

 

 

 

 

 

 

 

Net operating loss

 

$

8,532,000

 

$

6,217,000

 

Stock-based compensation

 

 

2,682,000

 

 

1,622,000

 

Research and development tax credits

 

 

400,000

 

 

 

Accounts payable amounts not currently deductible

 

 

140,000

 

 

632,000

 

Intangible assets – impairment

 

 

172,000

 

 

234,000

 

Vacation accrual

 

 

14,000

 

 

9,000

 

Other

 

 

 

 

 

7,000

 

Valuation allowance

 

 

(11,940,000

)

 

(8,721,000

)

 

 



 



 

Total

 

$

 

$

 

 

 



 



 

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] The components of the provision for income taxes consist of the following:

 

 

 

 

 

 

 

 

 

 

For the Years Ended June 30,

 

 

 


 

 

 

2012

 

2011

 

 

 


 


 

Current - Federal and state

 

$

 

$

 

Deferred - Federal

 

 

(2,802,000

)

 

(4,128,000

)

Deferred - state

 

 

(417,000

)

 

(192,000

)

 

 



 



 

Total

 

 

(3,219,000

)

 

(4,320,000

)

Change in valuation allowance

 

 

3,219,000

 

 

4,320,000

 

 

 



 



 

Income tax expense

 

$

 

$

 

 

 



 



 

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] A reconciliation of the statutory tax rate to the effective tax rate is as follows:

 

 

 

 

 

 

 

 

 

Years Ended June 30,

 

 

 


 

 

 

2012

 

2011

 

 

 


 


 

 

 

 

 

 

 

 

 

Statutory Federal income tax rate

 

 

34

%

 

34

%

State (net of Federal benefit)

 

 

6

%

 

6

%

Non-deductible expenses - change in fair value of derivative financial liability

 

 

26

%

 

(7

%)

Research and development tax credit

 

 

7

%

 

Non utilization of state operating loss (1)

   

(12

%)

 

 

Other

 

 

(4

%)

 

(3

%)

Change in valuation allowance

 

 

(57

%)

 

(30

%)

 

 



 



 

Effective income tax rate

 

 

0

%

 

0

%